bibliographicCitation |
Wachters FM, Groen HJM, Biesma B, Schramel FMNH, Postmus PE, Stigt JA, Smit EF. A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment. British Journal of Cancer. 2004 Dec 14;92(1):15–20. doi: 10.1038/sj.bjc.6602268. |